Advertisement

Intermediate repeat expansions of TBP and STUB1: Genetic modifier or pure digenic inheritance in spinocerebellar ataxias?

Published:November 23, 2022DOI:https://doi.org/10.1016/j.gim.2022.10.009

      Abstract

      Purpose

      CAG/CAA repeat expansions in TBP>49 are responsible for spinocerebellar ataxia (SCA) type 17 (SCA17). We previously detected cosegregation of STUB1 variants causing SCA48 with intermediate alleles of TBP in 2 families. This cosegregation questions the existence of SCA48 as a monogenic disease.

      Methods

      We systematically sequenced TBP repeats in 34 probands of dominant ataxia families with STUB1 variants. In addition, we searched for pathogenic STUB1 variants in probands with expanded alleles of TBP>49 (n = 2) or intermediate alleles of TBP≥40 (n = 47).

      Results

      STUB1 variants were found in half of the TBP40-49 cohort. Mirroring this finding, TBP40-49 alleles were detected in 40% of STUB1 probands. The longer the TBP repeat length, the more likely the occurrence of cognitive impairment (P = .0129) and the faster the disease progression until death (P = .0003). Importantly, 13 STUB1 probands presenting with the full SCA48 clinical phenotype had normal TBP37-39 alleles, excluding digenic inheritance as the sole mode.

      Conclusion

      We show that intermediate TBP40-49 alleles act as disease modifiers of SCA48 rather than a STUB1/TBP digenic model. This distinction from what has been proposed before has crucial consequences for genetic counseling in SCA48.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      ACMG Member Login

      Are you an ACMG Member? Sign in for online access.

      Subscribe:

      Subscribe to Genetics in Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Koide R.
        • Kobayashi S.
        • Shimohata T.
        • et al.
        A neurological disease caused by an expanded CAG trinucleotide repeat in the TATA-binding protein gene: a new polyglutamine disease?.
        Hum Mol Genet. 1999; 8: 2047-2053https://doi.org/10.1093/hmg/8.11.2047
        • Toyoshima Y.
        • Onodera O.
        • Yamada M.
        • Tsuji S.
        • Takahashi H.
        Spinocerebellar ataxia Type 17.
        in: Adam M.P. Ardinger H.H. Pagon R.A. GeneReviews® [Internet]. University of Washington, 1993
        http://www.ncbi.nlm.nih.gov/books/NBK1438/
        Date accessed: June 23, 2021
        • Gao R.
        • Matsuura T.
        • Coolbaugh M.
        • et al.
        Instability of expanded CAG/CAA repeats in spinocerebellar ataxia type 17.
        Eur J Hum Genet. 2008; 16: 215-222https://doi.org/10.1038/sj.ejhg.5201954
        • Depienne C.
        • Mandel J.L.
        30 years of repeat expansion disorders: what have we learned and what are the remaining challenges?.
        Am J Hum Genet. 2021; 108: 764-785https://doi.org/10.1016/j.ajhg.2021.03.011
        • Oda M.
        • Maruyama H.
        • Komure O.
        • et al.
        Possible reduced penetrance of expansion of 44 to 47 CAG/CAA repeats in the TATA-binding protein gene in spinocerebellar ataxia type 17.
        Arch Neurol. 2004; 61: 209-212https://doi.org/10.1001/archneur.61.2.209
        • Zühlke C.
        • Dalski A.
        • Schwinger E.
        • Finckh U.
        Spinocerebellar ataxia type 17: report of a family with reduced penetrance of an unstable Gln49 TBP allele, haplotype analysis supporting a founder effect for unstable alleles and comparative analysis of SCA17 genotypes.
        BMC Med Genet. 2005; 6: 27https://doi.org/10.1186/1471-2350-6-27
        • Genis D.
        • Ortega-Cubero S.
        • San Nicolás H.
        • et al.
        Heterozygous STUB1 mutation causes familial ataxia with cognitive affective syndrome (SCA48).
        Neurology. 2018; 91: e1988-e1998https://doi.org/10.1212/WNL.0000000000006550
        • Roux T.
        • Barbier M.
        • Papin M.
        • et al.
        Clinical, neuropathological, and genetic characterization of STUB1 variants in cerebellar ataxias: a frequent cause of predominant cognitive impairment.
        Genet Med. 2020; 22 (Published correction appears in Genet Med. 2021;23(10):2021): 1851-1862
        • Magri S.
        • Nanetti L.
        • Gellera C.
        • et al.
        Digenic inheritance of STUB1 variants and TBP polyglutamine expansions explains the incomplete penetrance of SCA17 and SCA48.
        Genet Med. 2022; 24: 29-40https://doi.org/10.1016/j.gim.2021.08.003
        • Fujigasaki H.
        • Martin J.J.
        • De Deyn P.P.
        • et al.
        CAG repeat expansion in the TATA box-binding protein gene causes autosomal dominant cerebellar ataxia.
        Brain. 2001; 124: 1939-1947https://doi.org/10.1093/brain/124.10.1939
        • Shatunov A.
        • Fridman E.A.
        • Pagan F.I.
        • et al.
        Small de novo duplication in the repeat region of the TATA-box-binding protein gene manifest with a phenotype similar to variant Creutzfeldt-Jakob disease.
        Clin Genet. 2004; 66: 496-501https://doi.org/10.1111/j.1399-0004.2004.00356.x
        • Desvignes J.P.
        • Bartoli M.
        • Delague V.
        • et al.
        VarAFT: a variant annotation and filtration system for human next generation sequencing data.
        Nucleic Acids Res. 2018; 46: W545-W553https://doi.org/10.1093/nar/gky471
        • Folstein M.F.
        • Folstein S.E.
        • McHugh P.R.
        ‘Mini-mental state’. A practical method for grading the cognitive state of patients for the clinician.
        J Psychiatr Res. 1975; 12: 189-198https://doi.org/10.1016/0022-3956(75)90026-6
        • Dubois B.
        • Slachevsky A.
        • Litvan I.
        • Pillon B.
        The FAB: a Frontal Assessment Battery at bedside.
        Neurology. 2000; 55: 1621-1626https://doi.org/10.1212/wnl.55.11.1621
        • Golden C.J.
        Identification of brain disorders by the Stroop Color and Word Test.
        J Clin Psychol. 1976; 32: 654-658https://doi.org/10.1002/1097-4679(197607)32:3<654::aid-jclp2270320336>3.0.co;2-z
        • Nelson H.E.
        A modified card sorting test sensitive to frontal lobe defects.
        Cortex. 1976; 12: 313-324https://doi.org/10.1016/S0010-9452(76)80035-4
        • Buschke H.
        Cued recall in amnesia.
        J Clin Neuropsychol. 1984; 6: 433-440https://doi.org/10.1080/01688638408401233
        • Grober E.
        • Buschke H.
        • Crystal H.
        • Bang S.
        • Dresner R.
        Screening for dementia by memory testing.
        Neurology. 1988; 38: 900-903https://doi.org/10.1212/WNL.38.6.900
        • Schmahmann J.D.
        • Sherman J.C.
        The cerebellar cognitive affective syndrome.
        Brain. 1998; 121: 561-579https://doi.org/10.1093/brain/121.4.561
        • Hayer S.N.
        • Deconinck T.
        • Bender B.
        • et al.
        STUB1/CHIP mutations cause Gordon Holmes syndrome as part of a widespread multisystemic neurodegeneration: evidence from four novel mutations.
        Orphanet J Rare Dis. 2017; 12: 31https://doi.org/10.1186/s13023-017-0580-x
        • Pakdaman Y.
        • Berland S.
        • Bustad H.J.
        • et al.
        Genetic dominant variants in STUB1, segregating in families with SCA48, display in vitro functional impairments indistinctive from recessive variants associated with SCAR16.
        Int J Mol Sci. 2021; 22: 5870https://doi.org/10.3390/ijms22115870
        • Rolfs A.
        • Koeppen A.H.
        • Bauer I.
        • et al.
        Clinical features and neuropathology of autosomal dominant spinocerebellar ataxia (SCA17).
        Ann Neurol. 2003; 54: 367-375https://doi.org/10.1002/ana.10676
        • Stevanin G.
        • Fujigasaki H.
        • Lebre A.S.
        • et al.
        Huntington’s disease-like phenotype due to trinucleotide repeat expansions in the TBP and JPH3 genes.
        Brain. 2003; 126: 1599-1603https://doi.org/10.1093/brain/awg155
        • Zühlke C.
        • Gehlken U.
        • Hellenbroich Y.
        • Schwinger E.
        • Bürk K.
        Phenotypical variability of expanded alleles in the TATA-binding protein gene. Reduced penetrance in SCA17?.
        J Neurol. 2003; 250: 161-163https://doi.org/10.1007/s00415-003-0958-7
        • Tremolizzo L.
        • Curtò N.A.
        • Marzorati L.
        • et al.
        Early-onset SCA17 with 43 TBP repeats: expanding the phenotype?.
        Neurol Sci. 2011; 32: 941-943https://doi.org/10.1007/s10072-011-0662-9
        • Heimdal K.
        • Sanchez-Guixé M.
        • Aukrust I.
        • et al.
        STUB1 mutations in autosomal recessive ataxias – evidence for mutation-specific clinical heterogeneity.
        Orphanet J Rare Dis. 2014; 9: 146https://doi.org/10.1186/s13023-014-0146-0
        • Elden A.C.
        • Kim H.J.
        • Hart M.P.
        • et al.
        Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS.
        Nature. 2010; 466: 1069-1075https://doi.org/10.1038/nature09320
        • Lattante S.
        • Millecamps S.
        • Stevanin G.
        • et al.
        Contribution of ATXN2 intermediary polyQ expansions in a spectrum of neurodegenerative disorders.
        Neurology. 2014; 83: 990-995https://doi.org/10.1212/WNL.0000000000000778
        • Rosas I.
        • Martínez C.
        • Clarimón J.
        • et al.
        Role for ATXN1, ATXN2, and HTT intermediate repeats in frontotemporal dementia and Alzheimer’s disease.
        Neurobiol Aging. 2020; 87: 139.e1-139.e7https://doi.org/10.1016/j.neurobiolaging.2019.10.017
        • Reis M.C.
        • Patrun J.
        • Ackl N.
        • et al.
        A severe dementia syndrome caused by intron retention and cryptic splice site activation in STUB1 and exacerbated by TBP repeat expansions.
        Front Mol Neurosci. 2022; 15878236https://doi.org/10.3389/fnmol.2022.878236
        • Gostout B.
        • Liu Q.
        • Sommer S.S.
        ‘Cryptic’ repeating triplets of purines and pyrimidines (cRRY(i)) are frequent and polymorphic: analysis of coding cRRY (i) in the proopiomelanocortin (POMC) and TATA-binding protein (TBP) genes.
        Am J Hum Genet. 1993; 52: 1182-1190
        • Lescure A.
        • Lutz Y.
        • Eberhard D.
        • et al.
        The N-terminal domain of the human TATA-binding protein plays a role in transcription from TATA-containing RNA polymerase II and III promoters.
        EMBO J. 1994; 13: 1166-1175https://doi.org/10.1002/j.1460-2075.1994.tb06366.x
        • Kuddus R.
        • Schmidt M.C.
        Effect of the non-conserved N-terminus on the DNA binding activity of the yeast TATA binding protein.
        Nucleic Acids Res. 1993; 21 (Published correction appears in Nucleic Acids Res. 1993;21(12):2962): 1789-1796
        • Bettencourt C.
        • de Yébenes J.G.
        • López-Sendón J.L.
        • et al.
        Clinical and neuropathological features of spastic ataxia in a Spanish family with novel compound heterozygous mutations in STUB1.
        Cerebellum. 2015; 14: 378-381https://doi.org/10.1007/s12311-014-0643-7
        • Chen D.H.
        • Latimer C.
        • Yagi M.
        • et al.
        Heterozygous STUB1 missense variants cause ataxia, cognitive decline, and STUB1 mislocalization.
        Neurol Genet. 2020; 6: 1-13https://doi.org/10.1212/NXG.0000000000000397
        • Mol M.O.
        • van Rooij J.G.J.
        • Brusse E.
        • et al.
        Clinical and pathologic phenotype of a large family with heterozygous STUB1 mutation.
        Neurol Genet. 2020; 6: e417https://doi.org/10.1212/NXG.0000000000000417
        • Barman P.
        • Sen R.
        • Kaja A.
        • et al.
        Genome-wide regulations of the preinitiation complex formation and elongating RNA polymerase II by an E3 ubiquitin ligase.
        San1. Mol Cell Biol. 2022; 42e0036821https://doi.org/10.1128/MCB.00368-21